Националната кардиологична болница е многопрофилна болница за активно лечение в София. Тя е университетска болница – част от структурата на Софийския медицински университет. МБАЛ „НКБ“ е единствената болница в България с отделения за детска кардиология и детска кардиохирургия.

During the past decade, National Heart Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Heart Hospital" #1 sponsor was "Actelion" with 3 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "KU Leuven" with 1 trials sponsored and "Terumo Europe N.V." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "National Heart Hospital" are "Coronary Artery Disease" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Acute Myocardial Infarction" (1 trials), "Congenital Heart Disease" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "National Heart Hospital" in a lesser frequency.

Most popular intervention types in "National Heart Hospital" are "Drug" (4 trials), "Combination Product" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Macitentan 10 mg" (2 trials), "Cladribine" (1 trials), "FDC macitentan/tadalafil" (1 trials) and "Intracoronary ECG" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Heart Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "National Heart Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in National Heart Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Heart Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

National Heart Hospital has several departments that took part in Clinical trials: "MHAT National Cardiology Hospital EAD" - 16 trials